True Wealth Design, LLC Laboratory Corp Of America Holdings Transaction History

True Wealth Design, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $418 - $465	2 Added 100.0%	4 $874,000
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $197 - $227	-1 Reduced 33.33%	2 $455,000
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $647,381 - $713,874	-3,220 Reduced 99.91%	3 $604,000
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $1,695 - $1,930	-8 Reduced 0.25%	3,223 $778 Million
Q1 2023 May 12, 2023	BUY	$213.32 - $257.83 $1,919 - $2,320	9 Added 0.28%	3,231 $741 Million
Q4 2022 Feb 15, 2023	BUY	$203.72 - $248.97 $656,385 - $802,181	3,222 New	3,222 $759 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

Stay updated on True Wealth Design, LLC with notifications on news.